These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 708161)

  • 61. Prediction of serum concentration time course of quinidine in human using a physiologically based pharmacokinetic model developed from the rat.
    Harashima H; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharmacobiodyn; 1986 Feb; 9(2):132-8. PubMed ID: 3712213
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impairment of human drug metabolism by oral contraceptive steroids.
    O'Malley K; Stevenson IH; Crooks J
    Clin Pharmacol Ther; 1972; 13(4):552-7. PubMed ID: 5042369
    [No Abstract]   [Full Text] [Related]  

  • 63. Letter: Antipyrine half life and clearance in clinical practice.
    Whitling B; Ullah M; Meredith PA
    Br Med J; 1976 Aug; 2(6033):471. PubMed ID: 953613
    [No Abstract]   [Full Text] [Related]  

  • 64. [Liver capacity in the biotransformation of drugs in patients with chronic circulatory failure (kinetics of antipyrine and indocyanine green)].
    Adamska-Dyniewska H
    Pol Arch Med Wewn; 1978 Oct; 60(4):313-8. PubMed ID: 714726
    [No Abstract]   [Full Text] [Related]  

  • 65. Changes in human drug metabolism after long-term exposure to hypnotics.
    Stevenson IH; Browning M; Crooks J; O'Malley K
    Br Med J; 1972 Nov; 4(5836):322-4. PubMed ID: 4637511
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hypermetabolism of phenytoin as a cause of treatment failure.
    Lebrun LH; Villeneuve JP
    Clin Neuropharmacol; 1983 Mar; 6(1):67-70. PubMed ID: 6850652
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessment of methods to identify sources of interindividual pharmacokinetic variations.
    Vesell ES; Penno MB
    Clin Pharmacokinet; 1983; 8(5):378-409. PubMed ID: 6194927
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drugs and genes.
    Motulsky AG
    Ann Intern Med; 1969 Jun; 70(6):1269-72. PubMed ID: 4182785
    [No Abstract]   [Full Text] [Related]  

  • 69. Drug distribution as a function of binding competition. Experiments with the distribution dialysis technique.
    Bickel MH; Gerny R
    J Pharm Pharmacol; 1980 Oct; 32(10):669-74. PubMed ID: 6107337
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Phenotyping by total oxidative hepatic capacity in patients undergoing laparoscopic cholecystectomy: two categories of patients and duration of post-anesthesia rehabilitation].
    Chuenkova EA; Ziganshina LE
    Eksp Klin Farmakol; 2013; 76(7):35-8. PubMed ID: 24006615
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Upjohn Award Lecture 1981/La Conférence Upjohn 1981. The metabolism of xenobiotics in different populations.
    Kalow W
    Can J Physiol Pharmacol; 1982 Jan; 60(1):1-12. PubMed ID: 7039786
    [No Abstract]   [Full Text] [Related]  

  • 72. Disposition and oxidative metabolism of antipyrine in the rat.
    Aarbakke J
    Acta Pharmacol Toxicol (Copenh); 1978 Jul; 43(1):64-8. PubMed ID: 707125
    [No Abstract]   [Full Text] [Related]  

  • 73. Disposition and oxidative metabolism of phenylbutazone in man.
    Aarbakke J; Bakke OM; Milde EJ; Davies DS
    Eur J Clin Pharmacol; 1977; 11(5):359-66. PubMed ID: 880975
    [No Abstract]   [Full Text] [Related]  

  • 74. Pharmacokinetics of phenylbutazone in chronic liver disease.
    Adithan C; Shashindran CH; Gandhi IS; Singh DS; Balachandar J
    Indian J Med Res; 1980 Feb; 71():316-21. PubMed ID: 7380508
    [No Abstract]   [Full Text] [Related]  

  • 75. Drug therapy in the elderly.
    Wade OL
    Age Ageing; 1972 May; 1(2):65-73. PubMed ID: 4669868
    [No Abstract]   [Full Text] [Related]  

  • 76. In vitro studies on the metabolism of antipyrine in the pig and rat: with special reference to veterinary medicine licensing.
    Sainz-Pardo Clares LA; Shaw IC
    Hum Exp Toxicol; 1993 Nov; 12(6):537-9. PubMed ID: 7904472
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Metabolism of drugs. LXXVII. In vitro metabolism of antipyrine].
    Shimeno H; Yoshimura H
    Yakugaku Zasshi; 1972 Nov; 92(11):1376-9. PubMed ID: 4675502
    [No Abstract]   [Full Text] [Related]  

  • 78. [Phenylbutazone and glycogen: effect of phenylbutazone therapy on the glycogen content of the liver, heart and muscles of normal rabbits of both sexes].
    CHITI E; ASTENGO F
    Arch Maragliano Patol Clin; 1955 Aug; 11(1):157-61. PubMed ID: 13276108
    [No Abstract]   [Full Text] [Related]  

  • 79. Phenytoin overview--metabolite interference in some immunoassays could be clinically important.
    Roberts WL; Rainey PM
    Arch Pathol Lab Med; 2004 Jul; 128(7):734; author reply 734-5. PubMed ID: 15229987
    [No Abstract]   [Full Text] [Related]  

  • 80. Antipyrine induction and hepatic vitamin D hydroxylation in man [proceedings].
    Brodie MJ; Davies DS; Dollery CT; Fraser HS; Hillyard CJ; MacIntyre I; Mucklow JE; Wilmana PF
    Br J Clin Pharmacol; 1979 Apr; 7(4):417P. PubMed ID: 444367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.